338 results on '"Mosseri, V."'
Search Results
52. 15 Use of a geriatric assessment questionnaire for older patients in an oncology clinic. Descriptive study of 105 patients at the Institut Curie, a French cancer treatment center
53. Treatment of high risk medulloblastomas in children above the age of 3 years: A SFOP study
54. Multicentre combined chemotherapy protocol for large cell advanced non hodgkin's lymphoma
55. Dose-intensified chemotherapy and additional Docetaxel may improve inflammatory breast cancer patients outcome over two decades: Results from Institut Curie protocols 1977–1987 and two consecutive French multicenter trials Pegase 02 (1995–96) and Pegase 05 (1997–99)
56. Anal canal cancer treatment: practical limitations of routine prescription of concurrent chemotherapy and radiotherapy
57. 118 Conformal radiotherapy for carcinoma of the nasopharynx: pattern of acute and late toxicities
58. Osteosarcoma following retinoblastoma: Age at onset and latency period
59. Differential expression of Bax and Bcl-2 in the assessment of cellular dynamics in fine-needle samples of primary breast carcinomas
60. Detection and quantitation by fluorescence in situ hybridization (FISH) and image analysis ofHER-2/neu gene amplification in breast cancer fine-needle samples
61. Cosmetic Sequelae After Conservative Treatment for Breast Cancer: Classification and Results of Surgical Correction
62. S-phase fractions of breast cancer predict overall and post-relapse survival
63. Anemia is associated with lower local-regional control and survival after radiation therapy for head and neck cancer: a prospective study.
64. Predictors of clinical response to interleukin-2--based immunotherapy in melanoma patients: a French multiinstitutional study.
65. N-MYC amplification, loss of heterozygosity on the short arm of chromosome 1 and DNA ploidy in retinoblastoma
66. Étude prospective de la valeur pronostique de l'anémie sur une population de cancers ORL traités par irradiation exclusive
67. Adjuvant chemotherapy for soft-tissue sarcoma: review and meta-analysis of the published results of randomised clinical trials
68. Contralateral breast cancer: annual incidence and risk parameters.
69. Lack of efficacy of low‐dose subcutaneous recombinant interleukin‐2 and interferon‐a in the treatment of metastatic renal cell carcinoma
70. Etoposide and carboplatin in extraocular retinoblastoma: a study by the Société Française d'Oncologie Pédiatrique.
71. Breast cancer in elderly women: a retrospective analysis of combined treatment with tamoxifen and once-weekly irradiation
72. Serum interleukin 6 and C-reactive protein levels correlate with resistance to IL-2 therapy and poor survival in melanoma patients
73. Circulating levels of colony-stimulating factor 1 as a prognostic indicator in 82 patients with epithelial ovarian cancer
74. Prognostic factors in inflammatory breast cancer and therapeutic implications
75. Visualisation of the left anterior descending coronary artery on CT images used for breast radiotherapy planning.
76. Expression of Colony‐Stimulating Factor‐1 and Its Receptor (the Protein Product of c‐fms) in Invasive Breast Tumor Cells
77. Prognostic Value of the S-Phase Fraction of Breast Cancers Treated by Primary Radiotherapy or Neoadjuvant Chemotherapy
78. Fine needle cytology diagnosis and histological confrontation of 691 salivary gland tumors
79. Corrélation entre le taux sérique du CD16 soluble et le stade du myélome: étude de 214 sérums
80. A phase II study of etoposide, cisplatin plus methotrexate in patients with advanced refractory breast cancer
81. Management of the neck in no oral carcinoma
82. Induction chemotherapy in advanced head and neck tumors: Results of two randomized trials
83. Association of ki‐ras mutation with differentiation and tumor‐formation pathways in colorectal carcinoma
84. Prognostic factors of alveolar rhabdomyosarcoma in childhood. An international society of pediatric oncology study
85. Overall genomic pattern is a predictor of outcome in neuroblastoma.
86. The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report.
87. Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplification.
88. A prognostic score in histological node negative breast cancer
89. Localised and unresectable neuroblastoma in infants: excellent outcome with low-dose primary chemotherapy.
90. Analysing the effects of anaemia on local recurrence of head and neck cancer when covariate values are missing.
91. Detection and quantitation by fluorescence in situ hybridization (FISH) and image analysis of HER-2/neu gene amplification in breast cancer fine-needle samples.
92. Prognostic value of estrogen and progesterone receptors in operable breast cancer. Results of a univariate and multivariate analysis.
93. The role of chemotherapy in orbital involvement of retinoblastoma. The experience of a single institution with 33 patients.
94. Prognostic value of intratumoral interferon gamma messenger RNA expression in invasive cervical carcinomas.
95. Multicentre combined chemotherapy protocol for large cell advanced non hodgkin's lymphoma.
96. Induction Chemotherapy in Advanced Head and Neck Cancer Preliminary results of a randomized study.
97. N-MYCamplification, loss of heterozygosity on the short arm of chromosome 1 and DNA ploidy in retinoblastoma
98. IL-6 is a survival prognostic factor in renal cell carcinoma
99. Prospective evaluation of Nmyc amplification and deletion of the short arm of chromosome 1 in neuroblastoma tumours: a single institution study
100. Circulating macrophage colony stimulating factor as a marker of tumour progression
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.